Cargando…

Neutropenia in dogs receiving vincristine for treatment of presumptive immune‐mediated thrombocytopenia

BACKGROUND: Neutropenia is an adverse effect of vincristine when used in multidrug chemotherapy protocols. OBJECTIVE: To determine the incidence of neutropenia, identify potential risk factors for neutropenia, and determine the effect of neutropenia on outcome, in dogs receiving vincristine for trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaQuaglia, Kathryn A., Robertson, James B., Lunn, Katharine F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848356/ https://www.ncbi.nlm.nih.gov/pubmed/33421218 http://dx.doi.org/10.1111/jvim.16029

Ejemplares similares

Application of therapeutic plasma exchange in dogs with immune‐mediated thrombocytopenia
por: Kopecny, Lucy, et al.
Publicado: (2020)

Splenectomy in the management of primary immune‐mediated hemolytic anemia and primary immune‐mediated thrombocytopenia in dogs
por: Bestwick, Jason P., et al.
Publicado: (2022)

Presumptive non‐cirrhotic bleeding esophageal varices in a dog
por: Myers, Marc, et al.
Publicado: (2018)

Presumptive phenobarbital‐induced systemic lupus erythematosus in a domestic dog
por: Phillips, Erin, et al.
Publicado: (2023)

Presumptive iatrogenic hypoadrenocorticism induced by high‐dose ketoconazole administration in a dog
por: Hernandez‐Bures, Andrea, et al.
Publicado: (2019)

The use of autologous skeletal muscle progenitor cells for adjunctive treatment of presumptive urethral sphincter mechanism incompetence in female dogs
por: Vaden, Shelly L., et al.
Publicado: (2022)

Hemostatic profiles in dogs with sudden acquired retinal degeneration syndrome
por: Lynch, Alex M., et al.
Publicado: (2023)

Development and implementation of a novel immune thrombocytopenia bleeding score for dogs
por: Makielski, Kelly M., et al.
Publicado: (2018)

Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis
por: Steiner, Joerg M., et al.
Publicado: (2023)

Prevalence and Risk Factors for Presumptive Ascending/Descending Myelomalacia in Dogs after Thoracolumbar Intervertebral Disk Herniation
por: Balducci, F., et al.
Publicado: (2017)

Detection and dynamics of anti‐platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia
por: Shropshire, Sarah, et al.
Publicado: (2020)

Outcomes of esophageal and gastric bone foreign bodies in dogs
por: Barash, Nanelle R., et al.
Publicado: (2022)

Comparison of direct measurement of intracranial pressures and presumptive clinical and magnetic resonance imaging indicators of intracranial hypertension in dogs with brain tumors
por: Giannasi, Savannah, et al.
Publicado: (2020)

Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog
por: Butty, Emmanuelle Marie, et al.
Publicado: (2021)

Serum Thymidine Kinase 1, Canine‐C‐Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune‐Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy
por: Grobman, M., et al.
Publicado: (2017)

Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer
por: Burton, J.H., et al.
Publicado: (2016)

Platelet number and function in response to a single intravenous dose of vincristine
por: Allen, Erin C., et al.
Publicado: (2021)

Effects of desmopressin acetate administration in healthy dogs receiving prednisolone
por: Galati, Pamela, et al.
Publicado: (2021)

Immunoglobulin G and phosphatidylserine in regenerative and nonregenerative immune‐mediated anemias of dogs
por: Lucidi, Cynthia A., et al.
Publicado: (2021)

Serum interleukin 17 concentrations in dogs with immune‐mediated hemolytic anemia
por: Cuq, Benoît, et al.
Publicado: (2020)

Complications of Percutaneous Endoscopic Gastrostomy in Dogs and Cats Receiving Corticosteroid Treatment
por: Aguiar, J., et al.
Publicado: (2016)

Neutrophil Extracellular Traps in Plasma from Dogs with Immune‐mediated Hemolytic Anemia
por: Lawson, C., et al.
Publicado: (2017)

Cell‐Free DNA and DNase Activity in Dogs with Immune‐Mediated Hemolytic Anemia
por: Jeffery, U., et al.
Publicado: (2017)

Heparin‐Induced Hyperkalemia in a Dog Receiving Continuous Renal Replacement Treatment
por: Geesaman, B., et al.
Publicado: (2015)

Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin
por: Hallman, Briana E., et al.
Publicado: (2019)

Clinical features and outcomes in 38 dogs with cholelithiasis receiving conservative or surgical management
por: Allan, Frederik, et al.
Publicado: (2021)

Bacterial urinary tract infection and subclinical bacteriuria in dogs receiving antineoplastic chemotherapy
por: Harrer, Julia, et al.
Publicado: (2022)

Opportunistic Invasive Cutaneous Fungal Infections Associated with Administration of Cyclosporine to Dogs with Immune‐mediated Disease
por: McAtee, B.B., et al.
Publicado: (2017)

A retrospective study of adverse effects of mycophenolate mofetil administration to dogs with immune‐mediated disease
por: Fukushima, Kenjiro, et al.
Publicado: (2021)

Breed predispositions, clinical findings, and prognostic factors for death in dogs with nonregenerative immune‐mediated anemia
por: Woolhead, Vanessa L., et al.
Publicado: (2020)

Retrospective analysis of immunosuppressive and anti‐thrombotic protocols in nonassociative immune mediated hemolytic anemia in dogs
por: Weng, Jennifer, et al.
Publicado: (2023)

Immune Function in Critically Ill Dogs
por: Hoffman, D., et al.
Publicado: (2017)

Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin
por: Henry, C.J., et al.
Publicado: (2017)

Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018)

Blood Transfusions in Dogs and Cats Receiving Hemodialysis: 230 Cases (June 1997–September 2012)
por: Langston, C., et al.
Publicado: (2017)

Predicting Outcome in dogs with Primary Immune‐Mediated Hemolytic Anemia: Results of a Multicenter Case Registry
por: Goggs, R., et al.
Publicado: (2015)

Evaluation of membrane‐based therapeutic plasma exchange as adjunctive treatment for immune‐mediated hematologic disorders in dogs
por: Francey, Thierry, et al.
Publicado: (2021)

Urinary 11‐dehydrothromboxane B(2) concentrations in 20 dogs with primary immune‐mediated hemolytic anemia
por: Conway, Elizabeth A., et al.
Publicado: (2021)

The use of high‐dose immunoglobulin M‐enriched human immunoglobulin in dogs with immune‐mediated hemolytic anemia
por: Bestwick, Jason P., et al.
Publicado: (2021)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
por: Ames, Marisa K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m5kqbpidhfdjitnckg9umr3f7j